|Day Low/High||3.72 / 3.90|
|52 Wk Low/High||1.93 / 4.23|
On Monday, Ocean Bio-Chem (OBCI) reported higher earnings for the 2016 second quarter compared to a year ago.
-- Important Legal Victory for Company
-- Chlorine Dioxide Generator System Disinfectant for Hard, Non-Porous Surfaces --
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: None Downgrades: DOC, ECHO, EMC, EMR, KGJI, NSR, OBCI, PLD, RELV, THTI, TTMI, TV Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
-- Benchmark for Active Investment Strategies --
--Gas Price Drop Helps OBCI--
--Launching Product in Numerous Huge Markets--
Shares of Ocean Bio-Chem (Nasdaq:OBCI) have taken a tremendous swing upward. The stock is trading at $2.44 as of 1:15 p.m. ET, 20.2% above Monday's closing price of $2.03. Volume is at 24,954, 1.7 times the daily average of 14,300.
There's been a disconnect -- stocks have become more attractive as investors have soured on equities.
Director Christopher Masto sells 554,079 shares of Tempur-Pedic.
Zale was among several stocks trading below $5 moving on above-average volume during Wednesday's session.
Small-cap stocks slid with the larger market, as companies like Pantry issued subpar guidance.